Statin Use in the U.S. for Secondary Prevention of Cardiovascular Disease Remains Suboptimal

Conclusions:
Our study found there was no increase in the national rates of statin use following the ACC/AHA 2013 secondary prevention guideline and the availability of generic statins. Significant gender and ethnic disparities in ASCVD treatment remained in the United States.

Source: Journal of the American Board of Family Medicine - November 7, 2019 Category: Primary Care Authors: Ngo-Metzger, Q., Zuvekas, S., Shafer, P., Tracer, H., Borsky, A. E., Bierman, A. S. Tags: Original Research Source Type: research